Illumina
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 4 days.
- Recent price momentum is +26.1% on average (3-month/1-year).
- Main-fund capital flow has been a net inflow over the last 45 sessions.
- Short interest has risen to 5.3% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is below the 60-day average, a short-term downtrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Factor grades
Ranked against 2848 U.S. stocks StockVane covers.
Last computed: 2026-11-22 08:27 UTC
Data coverage: 6 of 6 factors. Missing data is not a zero score.
Valuation D-
How expensive the stock is versus earnings, sales and its own 5-year history.
| P/E (TTM) | 33.2x | Better than 19% |
| Forward P/E | 34.0x | Better than 14% |
| Price / Sales | 6.4x | Better than 17% |
| P/E vs own 5-yr range | 77th pctl | Better than 29% |
Growth B-
How fast revenue, profit and free cash flow are compounding.
| Revenue CAGR (3Y) | -1.8% | Better than 19% |
| Net income CAGR (3Y) | -2.7% | Better than 37% |
| Free cash flow CAGR (3Y) | 106.3% | Better than 94% |
Profitability A
How much profit the business keeps from each dollar of sales and capital.
| Gross margin | 66.1% | Better than 80% |
| Operating margin | 18.8% | Better than 74% |
| Net margin | 19.6% | Better than 79% |
| Return on equity | 33.4% | Better than 89% |
| Return on invested capital | 17.5% | Better than 87% |
Momentum B+
Recent price strength, skipping the latest month to avoid short-term noise.
| 3-month return | -12.1% | Better than 46% |
| 6-month return | 33.5% | Better than 91% |
| 12-month return (ex latest month) | 117.5% | Better than 96% |
| Distance below 52-week high | 37.7% | Better than 31% |
Financial Health B-
Balance-sheet strength: leverage, liquidity and interest coverage.
| Current ratio | 2.1x | Better than 58% |
| Debt to assets | 38.4% | Better than 29% |
| Interest coverage | 11.8x | Better than 75% |
| Free cash flow / net income | 109.5% | Better than 45% |
Analyst View C+
What the Street thinks: share of Buy ratings and upside to the average target.
| Analysts rating Buy | 53.3% | Better than 32% |
| Upside to average target | 37.8% | Better than 58% |
Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.
Performance
Key statistics
Price & volume
- Prev close
- 200.66
- Open
- 197.57
- Day range
- 191.25 - 199.24
- Avg price
- 193.86
- Volume
- 1.95M
- Turnover
- 378.82M
- Turnover ratei
- 1.30%
- Volume ratioi
- 1.27
- Amplitudei
- 3.98%
- 52-week rangei
- 112.65 - 309.35
Valuation
- P/Ei
- 35.38
- P/E (TTM)i
- 33.19
- P/Bi
- 9.27
- EPSi
- 5.45
- Book value / shi
- 20.80
- Net profit
- 824.04M
- Net assets
- 3.14B
Share structure
- Market cap
- 29.15B
- Float capi
- 29.06B
- Shares out
- 151.20M
- Float sharesi
- 150.73M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 1970-01-01
37.7% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
+28.43M net over the window
Short interest
- Shares short
- 8.02M
- % of floati
- 5.31%
- Days to coveri
- 3.67
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Illumina (ILMN)?
Illumina last traded at 192.82. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Illumina's market cap?
About 29.15B.
What is the P/E ratio of Illumina?
The trailing twelve-month P/E is 33.19. The Valuation tab shows it against the stock's own five-year range.
Does Illumina pay a dividend?
Illumina does not currently pay a regular dividend.
Is Illumina a buy according to analysts?
The consensus of 15 analysts is a Buy rating, with an average 12-month price target of 265.73, which implies 37.8% upside from the current price. This is not investment advice.
What is Illumina's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Illumina a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:00 · For reference only, not investment advice and not tailored to your situation.
Illumina discussion 0 comments